BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29301935)

  • 1. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells.
    Cribbs A; Hookway ES; Wells G; Lindow M; Obad S; Oerum H; Prinjha RK; Athanasou N; Sowman A; Philpott M; Penn H; Soderstrom K; Feldmann M; Oppermann U
    J Biol Chem; 2018 Feb; 293(7):2422-2437. PubMed ID: 29301935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
    Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
    J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.
    Kruidenier L; Chung CW; Cheng Z; Liddle J; Che K; Joberty G; Bantscheff M; Bountra C; Bridges A; Diallo H; Eberhard D; Hutchinson S; Jones E; Katso R; Leveridge M; Mander PK; Mosley J; Ramirez-Molina C; Rowland P; Schofield CJ; Sheppard RJ; Smith JE; Swales C; Tanner R; Thomas P; Tumber A; Drewes G; Oppermann U; Patel DJ; Lee K; Wilson DM
    Nature; 2012 Aug; 488(7411):404-8. PubMed ID: 22842901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
    Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
    Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H3K27 Demethylase Negatively Controls the Memory Formation of Antigen-Stimulated CD8
    Yamada T; Nabe S; Toriyama K; Suzuki J; Inoue K; Imai Y; Shiraishi A; Takenaka K; Yasukawa M; Yamashita M
    J Immunol; 2019 Feb; 202(4):1088-1098. PubMed ID: 30626691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JMJD3 downregulates IL4i1 aggravating lipopolysaccharide-induced acute lung injury via H3K27 and H3K4 demethylation.
    Gao Y; Wang N; Jia D
    Environ Toxicol; 2023 Mar; 38(4):754-769. PubMed ID: 36537648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons.
    Messer HG; Jacobs D; Dhummakupt A; Bloom DC
    J Virol; 2015 Mar; 89(6):3417-20. PubMed ID: 25552720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3K27 demethylases are dispensable for activation of Polycomb-regulated injury response genes in peripheral nerve.
    Duong P; Ma KH; Ramesh R; Moran JJ; Won S; Svaren J
    J Biol Chem; 2021 Jul; 297(1):100852. PubMed ID: 34090875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.
    Hong S; Cho YW; Yu LR; Yu H; Veenstra TD; Ge K
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18439-44. PubMed ID: 18003914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Chen D; Cai B; Zhu Y; Ma Y; Yu X; Xiong J; Shen J; Tie W; Zhang Y; Guo F
    Clin Epigenetics; 2024 Apr; 16(1):51. PubMed ID: 38576048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.
    Jia W; Wu W; Yang D; Xiao C; Su Z; Huang Z; Li Z; Qin M; Huang M; Liu S; Long F; Mao J; Liu X; Zhu YZ
    FASEB J; 2018 Jul; 32(7):4031-4042. PubMed ID: 29481307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
    Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR
    Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H3K27me3 Demethylase UTX Restrains Plasma Cell Formation.
    Kania AK; Price MJ; George-Alexander LE; Patterson DG; Hicks SL; Scharer CD; Boss JM
    J Immunol; 2022 Apr; 208(8):1873-1885. PubMed ID: 35346967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Loss of H3K27 Histone Demethylase Utx in T Cells Aggravates Allergic Contact Dermatitis.
    Inoue T; Omori-Miyake M; Maruyama S; Okabe M; Kuwahara M; Honda H; Miura H; Yamashita M
    J Immunol; 2021 Nov; 207(9):2223-2234. PubMed ID: 34588217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.